INVESTOR RELATIONS

LATEST NEWS
TD Cowen 44th Annual Health Care Conference on March 5, 2024 at 12:50pm ET
Webcast >

CORPORATE OVERVIEW

Immunome is a biopharmaceutical company utilizing our proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome’s proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease.

LATEST PRESENTATION

JANUARY 2024

Immunome Corporate Presentation

LATEST EVENTS

1/11/2024 | 7:30am ET

42nd Annual J.P. Morgan Healthcare Conference

Menu